Although plasma miR‐675 was not deregulated in the entire BC group as well as in the single BC subgroups, its levels differed between lymph node‐negative and lymph node‐positive BC patients (P = 0.004) as well as HER2‐positive BC and the other subgroups (P = 0.007). The gene discussed is ERBB2; the disease is breast cancer.